Reversible contraception: Clinical sciences

4,774views

Reversible contraception: Clinical sciences

2nd semester of 4th grade

2nd semester of 4th grade

Approach to anxiety disorders: Clinical sciences
Generalized anxiety disorder, agoraphobia, and panic disorder: Clinical sciences
Obsessive compulsive disorder (OCD): Clinical sciences
Perinatal depression and anxiety: Clinical sciences
Specific phobia and social anxiety disorder (social phobia): Clinical sciences
Approach to joint pain and swelling: Clinical sciences
Gout: Clinical sciences
Osteoarthritis: Clinical sciences
Rheumatoid arthritis: Clinical sciences
Systemic lupus erythematosus: Clinical sciences
Approach to dyspnea: Clinical sciences
Asthma: Clinical sciences
Chronic obstructive pulmonary disease: Clinical sciences
Chronic kidney disease: Clinical sciences
Coronary artery disease: Clinical sciences
Peripheral arterial disease and ulcers: Clinical sciences
Approach to mood disorders: Clinical sciences
Bipolar I, bipolar II, and cyclothymic disorder: Clinical sciences
Major depressive disorder and persistent depressive disorder (dysthymia): Clinical sciences
Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD): Clinical sciences
Approach to lower limb edema: Clinical sciences
Congestive heart failure: Clinical sciences
Dyslipidemia: Clinical sciences
Approach to hypertension: Clinical sciences
Essential hypertension: Clinical sciences
Approach to involuntary movements: Clinical sciences
Approach to polyneuropathy: Clinical sciences
Obesity and metabolic syndrome: Clinical sciences
Obesity (pediatrics): Clinical sciences
Osteoporosis: Clinical sciences
Sleep apnea: Clinical sciences
Substance use disorder: Clinical sciences
Alcohol use disorder: Clinical sciences
Alcohol withdrawal: Clinical sciences
Opioid intoxication and overdose: Clinical sciences
Opioid use disorder: Clinical sciences
Opioid withdrawal syndrome: Clinical sciences
Tobacco use: Clinical sciences
Diabetes mellitus (pediatrics): Clinical sciences
Diabetes mellitus (Type 2): Clinical sciences
Hyperosmolar hyperglycemic state: Clinical sciences
Well-child visit (newborn and infant): Clinical sciences
Well-child visit (toddler and child): Clinical sciences
Well-child visit (adolescent): Clinical sciences
Well-patient care (GYN): Clinical sciences
Sports physical (pediatrics): Clinical sciences
Non-accidental trauma and neglect (pediatrics): Clinical sciences
Approach to delay or regression in developmental milestones: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Developmental milestones (childhood): Clinical sciences
Emergency contraception: Clinical sciences
Reversible contraception: Clinical sciences
Immunizations (pediatrics): Clinical sciences
Well-patient care (adult): Clinical sciences
Well-patient care (geriatrics): Clinical sciences
Intimate partner violence and sexual assault: Clinical sciences
Breast cancer screening: Clinical sciences
Cardiovascular disease screening: Clinical sciences
Cervical cancer screening: Clinical sciences
Colorectal cancer screening: Clinical sciences
Preconception care: Clinical sciences
Skin cancer screening: Clinical sciences
Sexually transmitted infection screening (Family medicine): Clinical sciences
Immunizations (adult): Clinical sciences

Decision-Making Tree

Transcript

Watch video only

Reversible contraception refers to any method of pregnancy prevention that doesn’t impact future fertility. Options for reversible contraception include hormonal birth control pills, patches, vaginal rings, and injections; long-acting-reversible-contraceptives, or LARC’s, such as implants and IUDs; and non-hormonal, non-LARC options like spermicides, fertility awareness, withdrawal and barrier methods. All individuals who desire contraception should be offered comprehensive counseling, with a focus on their values, preferences, and lived experiences. Shared decision-making is recommended when providing care to help individuals achieve their reproductive goals.

When a patient presents for reversible contraception, start with a focused history and physical exam. First, assess your patient’s preference and provide patient-centered contraceptive counseling. Be sure to incorporate a reproductive justice framework, which is focused on the understanding that all people have a fundamental right to bodily autonomy, to have or not have children, and to parent their children in safe and sustainable communities. Part of acknowledging this framework is awareness of the systemic and structural barriers that people of different descent, low incomes, mental illness, and incarceration have been subject to throughout history. Specifically, marginalized groups have undergone contraceptive experimentation without informed consent, government-sponsored forced sterilization, and other mistreatment.

As such, counseling should be viewed as an opportunity to review your patient's individual values, preferences, and lived experiences, in an open and safe environment. Additionally, take time to reflect and recognize any of your own unconscious or explicit biases that may influence the efficacy of your counseling. Finally, be sure to incorporate shared decision-making into your practice.

Next, assess your patient's medical eligibility criteria, or MEC, for each contraceptive method. The MEC is a set of standards that provides recommendations on the safety of contraceptives in the setting of different medical conditions.

During your history, assess the patient’s age and first day of their last menstrual period. Review their sexual history and 5 Ps, or partners, practices, past history of sexually transmitted infections, or STIs, prevention of STIs, and prevention of pregnancy. While this information is not absolutely required for contraception, it can help guide conversations on safe sexual practices and provide informed counseling.

Next, review medical conditions that are contraindicated for systemic hormonal contraception, including migraines with aura, hypertension, tobacco use, breast cancer, undiagnosed abnormal uterine bleeding, and acute liver disease.

Following this, assess for mental health conditions, specifically mood disorders like depression or bipolar disorder, as some patients may have worsening of symptoms with hormonal contraceptives. Also evaluate for mental or physical disabilities, which may limit a patient’s ability to reliably use contraceptives or tolerate placement of a LARC.

Additionally, review the patient's breastfeeding and postpartum status, as this will limit contraceptive options. Finally, review all medications, because certain anti-epileptic drugs, antibiotics, and antiretrovirals can reduce the efficacy of combined oral contraceptive pills, or COCs.

On physical exam, assess blood pressure and BMI. While routine pelvic exam and/or ultrasound is not necessary prior to prescribing contraception, you may opt to perform them if the patient desires an IUD to assess uterine size. If performing a pelvic exam, you can also evaluate for evidence of an active STI. For labs, obtain a pregnancy test and consider STI screening. If history and/or physical exam warrants further work-up, a pelvic ultrasound might be recommended.

Okay, if the pregnancy test is positive… perform individualized counseling. If negative, counsel on all reversible contraceptive options.

Let’s start with patients who desire hormonal, non-LARC, contraception. This includes combined oral contraceptive pills, or COCs, which contain both estrogen and progestin; and progestin-only pills, called POPs. There are also options for a combined estrogen-progestin contraceptive patch or vaginal ring, and a progestin-only injection called depot medroxyprogesterone acetate, or DMPA for short.

COCs work primarily by preventing ovulation, while also thickening cervical mucus making it more difficult for sperm to enter the uterus, and thinning the endometrium. Benefits of COCs include ease of access and use, plus non-contraceptive benefits like regular, lighter, and shorter menses, reduced menstrual cramps, and decreased risk of uterine, ovarian, and colon cancer. The biggest disadvantage is that patients must remember to take their pills at the same time every day!

Risks to COCs and other methods of combined hormonal contraception like the patch and vaginal ring, are rare but include a small increase in venous thromboembolism, or VTE, myocardial infarction, and stroke. This risk is highest in individuals over 35 years old who smoke more than 15 cigarettes a day, or in people with multiple cardiovascular risk factors or a history of migraines with aura.

Also, if your patient is postpartum, refrain from COCs for at least 21 days following delivery due to increased VTE risk, and avoid COCs in breastfeeding individuals as estrogen may affect milk production.

Sources

  1. "Patient-Centered Contraceptive Counseling: ACOG Committee Statement Number 1" Obstet Gynecol (2022)
  2. "Committee Opinion No. 710: Counseling adolescents about contraception" Obstet Gynecol (2017)
  3. "Practice Bulletin No. 186: Long-acting reversible contraception: implants and intrauterine devices" Obstet Gynecol (2017)
  4. "US Medical Eligibility Criteria (US-MEC) for contraceptive use" Centers for Disease Control and Prevention (2016)
  5. "Oral Contraceptive Pills" StatPearls (2022)
  6. "Progestin" StatPearls (2023)